Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. Kappos L, Wiendl H, Selmaj K, Arnold DL, Havrdova E, Boyko A, Kaufman M, Rose J, Greenberg S, Sweetser M, et al. N Engl J Med. 2015 Oct 8; 373(15):1418-28. PMID: 26444729. Abstract CommentRecommendBookmarkWatch